Results 151 to 158 of about 32,071 (158)

Remdesivir-Associated Pancreatitis

American Journal of Therapeutics, 2021
Abstract We report a case of acute pancreatitis that developed after four days of remdesivir therapy in a patient being treated for COVID-19. Despite improvement in patient's respiratory status, abdominal pain worsened and clinical signs and symptoms progressed to a diagnosis of acute pancreatitis 4 days after initiation of remdesivir therapy.
Shantanu Solanki, Karen Williams, Sushmita Khadka   +2 more
openaire   +2 more sources

Remdesivir-Induced Bradycardia

Southern Medical Journal, 2023
Remdesivir, a viral RNA-dependent RNA polymerase inhibitor, found extensive use in coronavirus disease 2019-infected patients because it curbs the viral load expansion. Among patients hospitalized as a result of lower respiratory tract infection, remdesivir proved to improve recovery time; however, remdesivir also can induce significant cytotoxic ...
Sai Gautham, Kanagala, Hardeep, Dholiya, Poonam, Jhajj, Meet A, Patel, Vasu, Gupta, Sachin, Gupta, Shiau-Ing, Wu, Rohit, Jain   +7 more
openaire   +2 more sources

Remdesivir for the treatment of COVID-19

Cochrane Database of Systematic Reviews, 2021
Remdesivir is an antiviral medicine with properties to inhibit viral replication of SARS-CoV-2. Positive results from early studies attracted media attention and led to emergency use authorisation of remdesivir in COVID-19.  A thorough understanding of the current evidence regarding the effects of remdesivir as a treatment for SARS-CoV-2 infection ...
Volker Thieme, Miriam Stegemann, Kelly Ansems, Karolina Dahms, Agata Mikolajewska, Maria-Inti Metzendorf, Felicitas Grundeis, Carina Benstoem, Falk Fichtner, Vanessa Piechotta   +9 more
openaire   +2 more sources

Taiwan's Efforts to Recreate Remdesivir

Biotechnology Law Report, 2021
This article reports Taiwan's efforts to replicate remdesivir to prepare for combating COVID-19.
openaire   +2 more sources

Remdesivir (Veklury)

Canadian Journal of Health Technologies
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire   +2 more sources

Synthesis of Remdesivir [PDF]

Synfacts, 2020
openaire   +1 more source

Synthesis of a Remdesivir Intermediate

Synfacts, 2020
openaire   +2 more sources